A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease
Clinical trial NCT01711866 · COMPLETED
Trial details
- NCT number
- NCT01711866
- Sponsor
- UCB BIOSCIENCES GmbH
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-03-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.